Trademark: 85085203
Word
LEADERSHIP IN NANOPHARMACEUTICALS
Status Date
Monday, March 17, 2014
Filing Date
Thursday, July 15, 2010
Published for Opposition
Tuesday, December 14, 2010
Abandoned Date
Monday, March 17, 2014
1 diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder
5 Pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical
"NANOPHARMACEUTICALS"
LEADERSHIP IN NANO PHARMACEUTICALS
Mar 17, 2014
Abandonment Notice Mailed - No Use Statement Filed
Mar 17, 2014
Abandonment - No Use Statement Filed
Aug 9, 2013
Notice Of Approval Of Extension Request Mailed
Aug 8, 2013
Extension 5 Granted
Jul 9, 2013
Extension 5 Filed
Aug 2, 2013
Case Assigned To Intent To Use Paralegal
Jul 9, 2013
Teas Extension Received
Jan 30, 2013
Notice Of Approval Of Extension Request Mailed
Jan 29, 2013
Extension 4 Granted
Jan 10, 2013
Extension 4 Filed
Jan 10, 2013
Teas Extension Received
Sep 5, 2012
Notice Of Approval Of Extension Request Mailed
Sep 5, 2012
Corrected Noa Mailed
Sep 4, 2012
Extension 3 Granted
Jul 24, 2012
Extension 3 Filed
Sep 4, 2012
Divisional Processing Complete
Jul 24, 2012
Divisional Request Received
Jul 24, 2012
Teas Request To Divide Received
Jul 24, 2012
Teas Extension Received
Mar 7, 2012
Notice Of Approval Of Extension Request Mailed
Mar 6, 2012
Extension 2 Granted
Feb 8, 2012
Extension 2 Filed
Mar 2, 2012
Case Assigned To Intent To Use Paralegal
Feb 8, 2012
Teas Extension Received
Jul 28, 2011
Notice Of Approval Of Extension Request Mailed
Jul 26, 2011
Extension 1 Granted
Jul 26, 2011
Extension 1 Filed
Jul 26, 2011
Teas Extension Received
Feb 8, 2011
Noa Mailed - Sou Required From Applicant
Dec 14, 2010
Published For Opposition
Nov 24, 2010
Notice Of Publication
Nov 10, 2010
Law Office Publication Review Completed
Nov 10, 2010
Assigned To Lie
Oct 29, 2010
Examiner's Amendment Mailed
Oct 28, 2010
Approved For Pub - Principal Register
Oct 28, 2010
Examiner's Amendment Entered
Oct 28, 2010
Examiners Amendment -Written
Oct 28, 2010
Assigned To Examiner
Jul 21, 2010
Notice Of Pseudo Mark Mailed
Jul 20, 2010
New Application Office Supplied Data Entered In Tram
Jul 19, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
